TY  - JOUR
AU  - Grasselli, J
AU  - Elez, E
AU  - Caratù, G
AU  - Matito, J
AU  - Santos, C
AU  - Macarulla, T
AU  - Vidal, J
AU  - Garcia, M
AU  - Viéitez, J M
AU  - Paéz, D
AU  - Falcó, E
AU  - Lopez Lopez, C
AU  - Aranda, E
AU  - Jones, F
AU  - Sikri, V
AU  - Nuciforo, P
AU  - Fasani, R
AU  - Tabernero, J
AU  - Montagut, C
AU  - Azuara, D
AU  - Dienstmann, R
AU  - Salazar, R
AU  - Vivancos, A
PY  - 2017
DO  - 10.1093/annonc/mdx112
UR  - http://hdl.handle.net/10668/11039
T2  - Annals of oncology : official journal of the European Society for Medical Oncology
AB  - Circulating tumor DNA (ctDNA) is a potential source for tumor genome analysis. We explored the concordance between the mutational status of RAS in tumor tissue and ctDNA in metastatic colorectal cancer (mCRC) patients to establish eligibility for...
LA  - en
KW  - RAS analysis
KW  - anti-EGFR therapy
KW  - circulating tumor DNA
KW  - metastatic colorectal cancer
KW  - Colorectal Neoplasms
KW  - ErbB Receptors
KW  - Genes, ras
KW  - Humans
KW  - Mutation
KW  - Neoplasm Metastasis
TI  - Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
TY  - research article
VL  - 28
ER  -